Status:
COMPLETED
Stage I Multiple Myeloma Treatment
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Multiple Myeloma
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
* Assessment of survival without progression of stage I MM in two groups: arm A: simple survey and arm B: administration of Zoledronate. * Describe different progression's type noticed and define the ...
Detailed Description
RATIONAL: Multiple Myeloma in spite of therapy progresses mainly due to stem cell auto transplant, still remain a deadly disease. About 2000 new cases are diagnosed every year in France. The asymptom...
Eligibility Criteria
Inclusion
- stage I multiple myeloma without bones injuries
Exclusion
- abnormal kidney function
- VIH infection
- Hepatic incapacity
- pregnancy
- Associate pathology
Key Trial Info
Start Date :
December 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2012
Estimated Enrollment :
89 Patients enrolled
Trial Details
Trial ID
NCT00733538
Start Date
December 1 2004
End Date
November 1 2012
Last Update
April 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Medecine interne, Hôpital l'ARCHET, CHU de Nice
Nice, France, 06202